WallStreetZenWallStreetZen

NASDAQ: XERS
Xeris Biopharma Holdings Inc Stock Ownership - Who owns Xeris Biopharma Holdings?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Xeris Biopharma Holdings Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kevin McCullochPresident and Chief Operating Officer2025-10-02733$8.31
$6.09kSell
Marla PerskyDirector2025-09-1115,500$7.72
$119.61kSell
Jeffrey W. ShermanDirector2025-08-2842,232$7.92
$334.52kSell
Jeffrey W. ShermanDirector2025-08-2847,040$6.66
$313.29kBuy
John JohnsonDirector2025-08-13107,500$7.32
$786.47kSell
Dawn HalkuffDirector2025-08-1242,500$7.28
$309.23kSell
John Patrick Shannon Jr.Chief Executive Officer and Director2025-08-0136,918$5.38
$198.62kSell
Kevin McCullochPresident and Chief Operating Officer2025-08-0114,651$5.38
$78.82kSell
Kevin McCullochPresident and Chief Operating Officer2025-06-1325,000$4.38
$109.47kBuy
Kevin McCullochPresident and Chief Operating Officer2025-04-02733$5.15
$3.77kSell

1 of 3

XERS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when XERS insiders and whales buy or sell their stock.

XERS Shareholders

What type of owners hold Xeris Biopharma Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc7.14%11,536,321$107.40MInstitution
Vanguard Group Inc6.08%9,816,937$91.40MInstitution
Redmile Group LLC3.35%5,413,284$50.40MInsider
Paul R. Edick2.40%3,868,354$36.01MInsider
D E Shaw Co Inc2.38%3,835,407$35.71MInstitution
State Street Corp2.34%3,783,200$35.22MInstitution
Geode Capital Management LLC2.26%3,650,688$33.99MInstitution
Morgan Stanley2.26%3,642,584$33.91MInstitution
Qube Research Technologies Ltd1.91%3,089,771$28.77MInstitution
Millennium Management LLC1.82%2,933,620$27.31MInstitution

1 of 3

XERS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
XERS56.04%15.19%Net SellingNet Selling
SYRE71.13%28.87%Net SellingNet Selling
BCRX84.08%15.92%Net SellingNet Buying
NTLA71.81%28.19%Net BuyingNet Buying
IMNM91.25%7.71%Net BuyingNet Buying
View Top Biotech Stocks

Xeris Biopharma Holdings Stock Ownership FAQ

Who owns Xeris Biopharma Holdings?

Xeris Biopharma Holdings (NASDAQ: XERS) is owned by 56.04% institutional shareholders, 15.19% Xeris Biopharma Holdings insiders, and 28.77% retail investors. Redmile Group LLC is the largest individual Xeris Biopharma Holdings shareholder, owning 5.41M shares representing 3.35% of the company. Redmile Group LLC's Xeris Biopharma Holdings shares are currently valued at $49.96M.

If you're new to stock investing, here's how to buy Xeris Biopharma Holdings stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.